BDSX Crosses Above Average Analyst Target
January 14, 2021 at 08:09 AM EST
In recent trading, shares of Biodesix Inc (BDSX) have crossed above the average analyst 12-month target price of $22.67, changing hands for $23.78/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..